Essential Therapeutics (ETRX) formerly Microcide (MCDE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John O'Neill who wrote (157)	9/4/1998 10:43:00 PM
From: jackie	Read Replies (1) of 415

John, I like this company. It is in a very strategic investing theme, dealing with antibiotic resistant bacteria. The general public is only gradually becoming aware of the dangers growing all around us. Doctors have been aware of this problem for some time, but that has not filtered down yet. In addition, the management knows how to husband its resources. These guys are getting other people to pay for their research. I like that. With the pummeling biotech has taken for sometime, this has to be attractive for the speculative investor. I think we will see a turn around in the biotech arena as some of the drugs coming onto market begin to make cash flow impacts on the companies owning them. It is show me time for biotech and I think they are getting ready to do just that. Regards, Jack Simmons

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next